pharma · Moderate to Severe Platysma Prominence · Chronic migraine
Merz Therapeutics
Merz Therapeutics GmbH
Merz Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
frankfurt am main, DE HQ
2020 Founded
1,312 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- frankfurt am main, DE
- Founded
- 2020
- Employees
- 1,312
- Programs
- 3
- Drugs
- 5
- Patents
- 0
Merz Therapeutics patents
0 pharmaceutical patents indexed for Merz Therapeutics. 0 expire within 24 months.
Merz Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Merz Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Merz Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.